Ditchcarbon
  • Contact
  1. Organizations
  2. Schering-Plough Corporation
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 3 months ago

Schering-Plough Corporation Sustainability Profile

Company website

Schering-Plough Corporation, a prominent player in the pharmaceutical and biotechnology industry, is headquartered in the United States. Founded in 1851, the company has a rich history marked by significant milestones, including its merger with Merck & Co. in 2009, which expanded its global reach and product portfolio. Schering-Plough is renowned for its innovative solutions in areas such as immunology, oncology, and cardiovascular health. Its core products, including specialty pharmaceuticals and biologics, are distinguished by their commitment to improving patient outcomes through advanced research and development. With a strong market position, Schering-Plough has achieved notable recognition for its contributions to healthcare, making it a trusted name in the industry. The company continues to focus on delivering unique therapies that address unmet medical needs, solidifying its reputation as a leader in the pharmaceutical landscape.

DitchCarbon Score

How does Schering-Plough Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

69

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Schering-Plough Corporation's score of 69 is higher than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.

83%

Let us know if this data was useful to you

Schering-Plough Corporation's reported carbon emissions

Inherited from Merck & Co., Inc.

Schering-Plough Corporation, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is part of a corporate family that includes Merck & Co., Inc., from which it inherits its climate commitments and performance metrics. As a merged entity, Schering-Plough's climate initiatives and reduction targets are aligned with those of Merck & Co., Inc. However, specific reduction targets or achievements for Schering-Plough itself are not detailed. The company is involved in broader industry efforts to address climate change, but without specific data, it is challenging to quantify its individual impact. The emissions data and climate commitments are cascaded from Merck & Co., Inc., which is actively engaged in sustainability initiatives and has set science-based targets for emissions reductions. This relationship underscores Schering-Plough's commitment to aligning with industry standards and contributing to climate action, although specific metrics for Schering-Plough remain unspecified.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20142015201620172018201920202021202220232024
Scope 1
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
1,532,400,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
5,760,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000

How Carbon Intensive is Schering-Plough Corporation's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Schering-Plough Corporation's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Schering-Plough Corporation's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Schering-Plough Corporation is in US, which has a low grid carbon intensity relative to other regions.

Schering-Plough Corporation's Scope 3 Categories Breakdown

Schering-Plough Corporation's Scope 3 emissions, which increased by 3% last year and increased by approximately 5% since 2014, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 78% of Scope 3 emissions.

Top Scope 3 Categories

2024
Purchased Goods and Services
78%
Upstream Transportation & Distribution
7%
Capital Goods
5%
Business Travel
3%
Employee Commuting
3%
Waste Generated in Operations
<1%
Franchises
<1%
Downstream Transportation & Distribution
<1%
Use of Sold Products
<1%

Schering-Plough Corporation's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Schering-Plough Corporation has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Schering-Plough Corporation's Emissions with Industry Peers

Braintree Laboratories, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 months ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Janssen Biotech, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 months ago

Nautilus Biotech S.A.

FR
•
Pharmaceutical Preparation Manufacturing
Updated 25 days ago

Ironwood Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Procter And Gamble

US
•
Chemicals nec
Updated about 1 month ago

Let us know if this data was useful to you

Usage Policy

You're welcome to quote or reference data from this page, but please include a visible link back to this URL.

Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.

See our License Agreement for more details.

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251211.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
Use CaseSBTi-aligned baselining & progress trackingSupplier EngagementClimate-informed sourcing strategyEmission ReportingSustainable Finance
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelogWhitepaper
AboutTeamCareersLicense AgreementPrivacy